Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

Buying Stocks Blindly
In the Hope They Will Go Up?


Here's A Better Way to Invest

**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

AD

List of Upcoming AGM/EGM in 2026 for BSE Healthcare Index

Here is the list of upcoming AGM/EGM in India. These companies have announced their AGM/EGM recently.

CompanyDateDetails
GLENMARK PHARMA
Sep 11, 2026A.G.M.
SHILPA MEDICARE
Sep 11, 2026A.G.M.
POLY MEDICURE
Sep 5, 2026A.G.M.
GUFIC BIOSCIENCE
Sep 4, 2026A.G.M.
PROCTER & GAMBLE HEALTH
Sep 3, 2026A.G.M.
IOL CHEMICALS & PHARM.
Sep 2, 2026A.G.M.
MARKSANS PHARMA.
Aug 27, 2026A.G.M.
AUROBINDO PHARMA
Aug 27, 2026A.G.M.
ALKEM LABORATORIES
Aug 27, 2026A.G.M.
KIMS
Aug 27, 2026A.G.M.
KOVAI MEDICAL
Aug 26, 2026A.G.M.
JUBILANT PHARMOVA
Aug 26, 2026A.G.M.
GLAND PHARMA
Aug 25, 2026A.G.M.
APOLLO HOSPITALS
Aug 25, 2026A.G.M.
SUVEN LIFE SCIENCES
Aug 25, 2026A.G.M.
NGL FINE CHM
Aug 25, 2026A.G.M.
VENUS REMEDIES
Aug 20, 2026A.G.M.
METROPOLIS HEALTHCARE
Aug 18, 2026A.G.M.
NARAYANA HRUDAYALAYA
Aug 14, 2026A.G.M.
IPCA LABS
Aug 13, 2026A.G.M.
ABBOTT INDIA
Aug 13, 2026A.G.M.
ANUH PHARMA
Aug 12, 2026A.G.M.
ZYDUS LIFESCIENCES
Aug 11, 2026A.G.M.
UNICHEM LAB
Aug 11, 2026A.G.M.
ALEMBIC
Aug 11, 2026A.G.M.
SEQUENT SCIENTIFIC
Aug 11, 2026A.G.M.
FORTIS HEALTHCARE
Aug 11, 2026A.G.M.
FERMENTA BIOTECH
Aug 11, 2026A.G.M.
SUN PHARMA ADV. RES.
Aug 10, 2026A.G.M.
DIVIS LABORATORIES
Aug 10, 2026A.G.M.
WOCKHARDT
Aug 10, 2026A.G.M.
ASTRAZENECA PHARMA
Aug 10, 2026A.G.M.
GRANULES INDIA
Aug 6, 2026A.G.M.
ALBERT DAVID
Aug 6, 2026A.G.M.
BIOCON
Aug 6, 2026A.G.M.
ALEMBIC PHARMA
Aug 5, 2026A.G.M.
NEULAND LABS
Aug 4, 2026A.G.M.
LUPIN
Aug 4, 2026A.G.M.
SUN PHARMA
Jul 31, 2026A.G.M.
MAX HEALTHCARE INSTITUTE
Jul 30, 2026A.G.M.
SYNGENE INTERNATIONAL
Jul 29, 2026A.G.M.
NURECA
Jul 28, 2026A.G.M.
PFIZER
Jul 28, 2026A.G.M.
DR. LAL PATHLABS
Jul 25, 2026A.G.M.
TTK HEALTHCARE
Jul 24, 2026A.G.M.
DR. REDDYS LAB
Jul 23, 2026A.G.M.
RPG LIFE SCIENCES
Jul 23, 2026A.G.M.
HESTER BIOSCIENCES
Jul 21, 2026A.G.M.
AJANTA PHARMA
Jul 16, 2026A.G.M.
BLISS GVS PHARMA
Jul 15, 2026A.G.M.
LAURUS LABS
Jul 2, 2026A.G.M.
GSK PHARMA
Jun 30, 2026A.G.M.
THYROCARE TECHNOLOGIES
Jun 30, 2026A.G.M.
CIPLA
Jun 25, 2026A.G.M.
J.B.CHEMICALS
Jun 17, 2026A.G.M.
SANOFI INDIA
Apr 29, 2026A.G.M.




FAQs

What are the upcoming AGMs/EGMs in August 2026?

BIKAJI FOODS, RESTAURANT BRANDS ASIA, CANARA HSBC LIFE INSURANCE COMPANY LTD. and CENTURY ENKA have their AGMs in August 2026.

For a comprehensive list, check out our list of upcoming AGMs in India.

What is AGM/EGM?

An annual general meeting (AGM) is a mandatory annual meeting of a company's executives, directors, and interested shareholders.

An extraordinary general meeting (EGM) is a shareholder meeting called other than a company's scheduled annual general meeting (AGM). An EGM is also called a special general meeting or emergency general meeting.

What is the difference between an AGM and EGM?

An AGM should be held at least once a year whereas there is no such stipulation for EGMs.

As the name suggests, only special business can be conducted in EGM whereas in an AGM ordinary business is conducted.

If an AGM is not held, the company is liable to a penalty. For EGMs there is no such penalty prescribed under law.



Today's Market

Greaves Cotton Acquires Remaining Stake in Excel Controlinkage | Lenskart Incorporates New Step-Down Subsidiary in China | Top Buzzing Stocks Today(Pre-Open)

Indian benchmark indices traded negative throughout the session and ultimately closed red.

PLEASE NOTE:
The information in the web site has been compiled from sources we believe to to be reliable, but we do not hold ourselves responsible for its completeness or accuracy. This is not an offer to sell or a solicitation to buy any securities. Investors are advised to read the offer document before making an investment decision.


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS

QUICK LINKS

POPULAR TOPICS

TRENDING TOPICS

FREE NEWSLETTERS

EQUITYMASTER SUPPORTS

HelpYourNGO

  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Quantum Information Services Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

  • Registered Name:

    Quantum Information Services Private Limited

  • Registered Office Address:

    103, Regent Chambers, Nariman Point, Mumbai 400021

  • CIN:

    U65990MH1989PTC054667

  • Website:

    www.equitymaster.com

  • Compliance Officer & Grievance Officer:

    Ms. Sonal Ramachandran

    | Telephone No.: +91-22-61434003 | Email: compliance@equitymaster.com

SEBI Registered Research Analyst Details:

SEBI Registration No.: INH000021128 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 6769

Principal Officer: Tanushree Banerjee | Telephone No.:+91-22-61434055 | Email: po.ra@equitymaster.com

SEBI Registered Investment Adviser Details:

SEBI Registration No.: INA000000680 | Type of Registration: Non-Individual | Validity: Perpetual | BSE Enlistment No: 1488

Principal Officer: Vivek Chaurasia | Telephone No.:+91-22-61434055 | Email: po.ria@equitymaster.com

SEBI Office Details:

SEBI Bhavan BKC
Address: Plot No.C4-A, 'G' Block Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra
Telephone No.: +91-22-26449000 / 40459000 | Fax: +91-22-26449019-22 / 40459019-22 | Email: sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575
SCORES: https://www.scores.gov.in/ | SMARTODR: https://smartodr.in/login

Association of Mutual Funds of India (AMFI) Registered Details:

AMFI Registered Mutual Fund Distributor
AMFI Registration Number : ARN - 1022
Date of Initial Registration : 28 / JAN / 2008
Current Validity of ARN upto : 28 / JAN / 2028

LEGAL DISCLAIMER:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, enlistment with BSE as IA and RA, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing any content from this website whether wholly or in part, for any purpose without the permission of Quantum Information Services Private Limited is strictly prohibited and shall be deemed to be copyright infringement.

Quantum Information Services Private Limited (QIS) is a SEBI registered Research Analyst (bearing registration no INH000021128) and Investment Adviser(Reg. No: INA000000680). Consequent upon the merger of Equitymaster Research Private Limited into QIS, effective October 30, 2025 QIS owns and operates brand 'Equitymaster' and website www.equitymaster.com. This does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities and QIS including its employees, personnel, directors, associates will not be liable for any losses (direct or indirect) incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. All content and information is provided on an 'As Is' basis by QIS. Information herein is believed to be reliable but QIS does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by QIS are on a best effort basis. QIS does not assure or guarantee the user any minimum or fixed returns. The securities quoted, if any are for illustration only and are not recommendatory. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject QIS or its affiliates to any registration or licensing requirement.

The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing QIS's content and website, you agree to our Terms and Conditions of Use, available here